Medication info

Robas Granules

Prescription medicationOralApproval withdrawn
Ingredient · strength
Sodium Bicarbonate›490mg / 1gTartaric Acid›490mg / 1g
Manufacturer / importer
Highpl Life Sciences Co., Ltd.
Appearance
White effervescent granules
Packaging
50 packets/box [4g/packet], 100 packets/box [4g/packet]
Approval status
Approval withdrawn

MFDS item code 199001546 · Notified 1990.08.22

This product's status changed to Approval withdrawn on 2024.04.29. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Improvement of contrast imaging during fluoroscopic examination of the stomach and duodenum
Who takes it
Adults
Adult dose
At the start of fluoroscopy, immediately before or after administration of the contrast agent, administer 1.0∼1.5 g orally per dose in adults, usually with a small amount of water or contrast agent, depending on age, individual differences in gastric contents, and the position for imaging. Adjust the dose as appropriate at the physician's discretion.

Ingredients

Manufacturer
Highpl Life Sciences Co., Ltd.

Efficacy & effects

Improvement of contrast imaging during fluoroscopic examination of the stomach and duodenum

View approved original text

This medication is used as an imaging aid during fluoroscopy of the stomach and duodenum. It helps to accurately confirm the structure and function of the gastrointestinal tract through fluoroscopy, providing significant assistance for diagnosis.

How to take

Adult dose

At the start of fluoroscopy, immediately before or after administration of the contrast agent, administer 1.0∼1.5 g orally per dose in adults, usually with a small amount of water or contrast agent, depending on age, individual differences in gastric contents, and the position for imaging. Adjust the dose as appropriate at the physician's discretion.

Precautions

This medication should not be used in patients with perforations of the gastrointestinal tract or suspected perforations, as the perforation site may enlarge or abdominal pain may intensify. Patients with acute bleeding in the gastrointestinal tract should also not be administered this medication, as there is a risk of worsening the bleeding site. It is advisable not to administer this medication to patients on a sodium-restricted diet. Caution should be exercised when administering to patients with or suspected of having fistulas in the gastrointestinal tract, as the fistula site may enlarge. Patients with or suspected of having gastrointestinal strictures or obstructions should also be observed carefully, as there is a risk of deteriorating the stricture or obstruction site. In patients at risk of gastrointestinal perforation, such as those with gastric or duodenal ulcers, diverticulitis, parasitic infections, or following tissue biopsy, this medication should be administered with caution. Patients with severe general weakness also require careful observation. Taking this medication may cause symptoms such as abdominal distension or belching. As carbon dioxide produced in the gastrointestinal tract can rapidly increase pressure within the tract, caution should be taken in patients suspected of gastrointestinal inflammation or bleeding, as symptoms may worsen. Additionally, due to increased gastrointestinal pressure, there have been reports of temporary hypotension, so blood pressure changes should be closely monitored during administration. For pregnant women or those who may become pregnant, safety has not been established, and it should only be administered when the diagnostic benefits outweigh the risks. There is limited experience in children, and safety has not been established; therefore, it should only be administered when the diagnostic benefits outweigh the risks, as an X-ray examination is necessary after administration of this medication. Elderly patients may have decreased gastrointestinal motility, so caution is necessary when using this medication, including dosage adjustments. Considering that about 130 milliliters of carbon dioxide is generated per gram of this medication, the dosage and the amount of gas produced should be appropriately adjusted. Lastly, this medication absorbs moisture readily, so care should be taken to avoid moisture exposure during storage.

Side effects

Abdominal bloating, belching

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a sealed container to protect it from air and moisture. Additionally, it is recommended to store it in a cool place between 1°C and 15°C.

Appearance and packaging

Appearance

White effervescent granules

Package unit

50 packets/box [4g/packet], 100 packets/box [4g/packet]

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.